Research Articles Library
Literature Analysis Tools
Advanced Search
Filter by PMID, year, source, DOI and other criteria
Literature Analysis
Analyze research trends and hotspots
Batch Export
Export search results to Excel/PDF
Trends and disparities in inflammatory bowel disease and cardiovascular disease-related mortality in the United States from 1999 to 2023: A CDC WONDER analysis
Publication Year: 2025 Source: Int J Cardiol Cardiovasc Risk Prev PMID: 40510678 DOI: 10.1016/j.ijcrp.2025.200438
BACKGROUND: Individuals with inflammatory Bowel Disease (IBD) may face an increased risk of cardiovascular disease (CVD) due to chronic systemic inflammation and vascular dysfunction. While advancements in treatment have improved IBD management, its impact on cardiovascular mortality remains unclear. This study aims to analyze trends in IBD- and CVD-related mortality …
Global, regional and national burden of inflammatory bowel disease in females from 1990 to 2021: an analysis of the global burden of disease study 2021
Publication Year: 2025 Source: Front Glob Womens Health PMID: 40510919 DOI: 10.3389/fgwh.2025.1580451
BACKGROUND & AIMS: The global incidence of inflammatory bowel disease (IBD) has markedly increased over past several decades. Gender-specific differences have been observed in the epidemiology, manifestation, and prognosis of IBD. Given these distinctions, a focused analysis of the latest epidemiological trends in female patients is essential for advancing targeted …
Exploring the systemic impacts of urinary tract infection-specific antibiotic treatments on the gut microbiome, metabolome, and intestinal morphology in rats
Publication Year: 2025 Source: PeerJ PMID: 40511381
The gut microbiota is a dynamic ecosystem that plays a crucial role in host metabolism, immune system regulation, and protection against pathogens. An imbalanced gut microbiota has been associated with various diseases such as inflammatory bowel disease, metabolic disorders, and autoimmune diseases. Antibiotic therapy can disrupt the balance of the …
Idiopathic Myointimal Hyperplasia of the Mesenteric Veins: Diagnosed After Resection due to Insufficient Palliative Surgery
Publication Year: 2025 Source: Surg Case Rep PMID: 40511447 DOI: 10.70352/scrj.cr.25-0129
INTRODUCTION: Idiopathic myointimal hyperplasia of the mesenteric veins (IMHMV) is a rare, non-thrombotic ischemic bowel disease caused by the proliferation of smooth muscle cells in the venous intima. Most patients are initially diagnosed with typical ischemic colitis or inflammatory bowel disease (IBD) and are treated nonsurgically. There is no established …
Venous Thromboembolism Prophylaxis Practice Patterns, Outcomes, and Risk Stratification after Surgery for Inflammatory Bowel Disease: A National Surgical Quality Improvement Program IBD Collaborative Study
Publication Year: 2025 Source: Dis Colon Rectum PMID: 40511773 DOI: 10.1097/DCR.0000000000003833
BACKGROUND: The optimal venous thromboembolism chemoprophylaxis strategy after surgery for inflammatory bowel disease is not defined. OBJECTIVE: To investigate the real-world efficacy of chemoprophylaxis strategies after surgery for inflammatory bowel disease in a retrospective cohort. DESIGN: From July 2020 to October 2023, the National Surgical Quality Improvement Program Inflammatory Bowel …
Live Malassezia strains from the mucosa of patients with ulcerative colitis: pathogenic potential and environmental adaptations
Publication Year: 2025 Source: mBio PMID: 40511923 DOI: 10.1128/mbio.01400-25
The human gut contains a diverse range of microorganisms, including bacteria, viruses, protozoa, and fungi. Although research has predominantly focused on bacterial populations, emerging evidence highlights the significant role of the gut mycobiota, particularly in the context of inflammatory bowel disease (IBD), including ulcerative colitis (UC) and Crohn's disease. This …
Bidirectional association of rheumatoid arthritis and inflammatory bowel diseases: a large-scale prospective cohort study
Publication Year: 2025 Source: Rheumatology (Oxford) PMID: 40511997 DOI: 10.1093/rheumatology/keaf337
OBJECTIVES: to investigate the bidirectional prospective association between inflammatory bowel disease (IBD) and rheumatoid arthritis (RA) in a large-scale, long-term follow-up, population-based cohort. METHODS: Participants free of any cancer at baseline were included and divided into two prospective cohorts: baseline IBD and incident RA cohort (cohort 1), and baseline RA …
Working together: gut microbe-microbe interactions shape host inflammation
Publication Year: 2025 Source: Infect Immun PMID: 40512008 DOI: 10.1128/iai.00512-24
Inflammatory bowel disease (IBD) is a debilitating disorder characterized by chronic intestinal inflammation that currently has no cure. Alterations to the composition of the gut microbiota, including reduced microbial diversity and expansion of pathobionts like Enterobacteriaceae, are implicated in IBD. While this dysbiosis has been well-documented, our understanding of the …
A Guide to the Patient-Centric Use of Vedolizumab for Crohn's Disease
Publication Year: 2025 Source: Inflamm Bowel Dis PMID: 40512051
Crohn's disease (CD) is a chronic, progressive, and debilitating disease characterized by inflammation of the gastrointestinal tract. It can have a significant impact on quality of life if not adequately controlled by appropriate treatment. In recent years, disease management strategies for CD have evolved from a focus on treating symptoms …
Safety and Effectiveness of QingDai (Indigo naturalis) in Children With Mild-to-Moderate Ulcerative Colitis: A Short-Term 6-Week Open-Label Trial
Publication Year: 2025 Source: Inflamm Bowel Dis PMID: 40512056
No Abstract
Need more literature?
The current database contains 98453 research articles. If you need to search for more literature or perform AI analysis, please use our knowledge acquisition module or explore external literature resources.
External Resources: Access comprehensive literature databases worldwide